# Promising Bimarker Prediction of Outcome of HELLP Syndrome.

> **NCT03246542** · — · COMPLETED · sponsor: **AYMAN ABDELKADER MOHAMED ABDELKADER** · enrollment: 100 (actual)

## Conditions studied

- Pre-Eclampsia, Severe
- HELLP Syndrome
- Microangiopathy

## Interventions

- **DIAGNOSTIC_TEST:** shistocytes percentage

## Key facts

- **NCT ID:** NCT03246542
- **Lead sponsor:** AYMAN ABDELKADER MOHAMED ABDELKADER
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2015-12-01
- **Final completion:** 2016-06-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246542, "Promising Bimarker Prediction of Outcome of HELLP Syndrome.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03246542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*